These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
153 related items for PubMed ID: 22122643
1. Antipsychotic subtypes can be characterized by differences in their ability to modify GABAergic promoter methylation. Dong E, Grayson DR, Guidotti A, Costa E. Epigenomics; 2009 Oct; 1(1):201-11. PubMed ID: 22122643 [Abstract] [Full Text] [Related]
2. Characterization of the action of antipsychotic subtypes on valproate-induced chromatin remodeling. Guidotti A, Dong E, Kundakovic M, Satta R, Grayson DR, Costa E. Trends Pharmacol Sci; 2009 Feb; 30(2):55-60. PubMed ID: 19110320 [Abstract] [Full Text] [Related]
5. The human reelin gene: transcription factors (+), repressors (-) and the methylation switch (+/-) in schizophrenia. Grayson DR, Chen Y, Costa E, Dong E, Guidotti A, Kundakovic M, Sharma RP. Pharmacol Ther; 2006 Jul; 111(1):272-86. PubMed ID: 16574235 [Abstract] [Full Text] [Related]
7. DNA-methyltransferase1 (DNMT1) binding to CpG rich GABAergic and BDNF promoters is increased in the brain of schizophrenia and bipolar disorder patients. Dong E, Ruzicka WB, Grayson DR, Guidotti A. Schizophr Res; 2015 Sep; 167(1-3):35-41. PubMed ID: 25476119 [Abstract] [Full Text] [Related]
8. GABAergic dysfunction in mGlu7 receptor-deficient mice as reflected by decreased levels of glutamic acid decarboxylase 65 and 67kDa and increased reelin proteins in the hippocampus. Wierońska JM, Brański P, Siwek A, Dybala M, Nowak G, Pilc A. Brain Res; 2010 Jun 02; 1334():12-24. PubMed ID: 20353761 [Abstract] [Full Text] [Related]
9. GABAergic promoter hypermethylation as a model to study the neurochemistry of schizophrenia vulnerability. Costa E, Chen Y, Dong E, Grayson DR, Kundakovic M, Maloku E, Ruzicka W, Satta R, Veldic M, Zhubi A, Guidotti A. Expert Rev Neurother; 2009 Jan 02; 9(1):87-98. PubMed ID: 19102671 [Abstract] [Full Text] [Related]
10. DNA-methyltransferase 1 mRNA is selectively overexpressed in telencephalic GABAergic interneurons of schizophrenia brains. Veldic M, Caruncho HJ, Liu WS, Davis J, Satta R, Grayson DR, Guidotti A, Costa E. Proc Natl Acad Sci U S A; 2004 Jan 06; 101(1):348-53. PubMed ID: 14684836 [Abstract] [Full Text] [Related]
11. S-adenosyl methionine and DNA methyltransferase-1 mRNA overexpression in psychosis. Guidotti A, Ruzicka W, Grayson DR, Veldic M, Pinna G, Davis JM, Costa E. Neuroreport; 2007 Jan 08; 18(1):57-60. PubMed ID: 17259861 [Abstract] [Full Text] [Related]
14. Dendritic spine hypoplasticity and downregulation of reelin and GABAergic tone in schizophrenia vulnerability. Costa E, Davis J, Grayson DR, Guidotti A, Pappas GD, Pesold C. Neurobiol Dis; 2001 Oct 08; 8(5):723-42. PubMed ID: 11592844 [Abstract] [Full Text] [Related]
15. Epigenetic modifications of GABAergic interneurons are associated with the schizophrenia-like phenotype induced by prenatal stress in mice. Matrisciano F, Tueting P, Dalal I, Kadriu B, Grayson DR, Davis JM, Nicoletti F, Guidotti A. Neuropharmacology; 2013 May 08; 68():184-94. PubMed ID: 22564440 [Abstract] [Full Text] [Related]
16. DNA methylation and demethylation as targets for antipsychotic therapy. Guidotti A, Grayson DR. Dialogues Clin Neurosci; 2014 Sep 08; 16(3):419-29. PubMed ID: 25364290 [Abstract] [Full Text] [Related]
17. Epigenetic regulation of RELN and GAD1 in the frontal cortex (FC) of autism spectrum disorder (ASD) subjects. Zhubi A, Chen Y, Guidotti A, Grayson DR. Int J Dev Neurosci; 2017 Nov 08; 62():63-72. PubMed ID: 28229923 [Abstract] [Full Text] [Related]